Tabex is an original preparation of plant origin, meant for the treatment of tobacco smoking. The preparation is established on the basis of the alkaloid Cystine, contained in the plant Cytisus laborinum L. (Golden Rain acacia). The broad scientific studies performed, reveal that the treatment with the preparation Tabex results in giving up smoking cigarettes in more than 57% of the patients.
e. the particular compound cytisine "replacements" nicotine, acting upon the very same receptors, hence preventing the look of abstinence syndrome. This results in a progressive decrease and suspension of the psychic and physical dependency to nicotine in cigarette smokers. Cytisine has a structure and mechanism of action that are similar to those of nicotine, however it has much lower toxicity.
Cytisus laborinum L the Tabex source plant aka Golder Rain acacia. Tabex is extremely well endured, and when applied in restorative doses, permits a progressive quiting of smoking cigarettes with no negative effects. The overall offering up of smoking ought to occur not behind the 5th day after the start of the treatment.
5 mg Citysine can assist to quit smoking cigarettes permanently.
Tabex UK. A leading provider of the original Tabex. nicotine patches , UK and Worldwide. Tabex is a supplement of plant origin by Sopharma Pharmaceuticals Bulgaria. Due to the popularity and the efficiency, demand of Tabex in UK and Australia has actually escalated in recent years. Tabex consists of the recognized plant extract Cytisine.
Tabex has been reported to be well tolerated and has been used by individuals worldwide. Tabex tablets do not contain hazardous Nicotine and is a supplement of strategy origin. Tabex tablets include 100% of the natural plant extract 'Cytisine' which is up to an amazing 500% more affordable than nicotine based solutions.
We only sell the original Tabex which is made by Sopharma Pharmaceuticals. Tabex is not a medicine or a prescription medication and is merely a supplement made of plant extract. No products promoted are planned to treat, treat or prevent any disease.
TABEX Hallmark Trademark Overview On Friday, September 9, 2005, a trademark application was filed for TABEX with the United States Patent and Trademark Office. The USPTO has provided the TABEX trademark an identification number of 79017271. The federal status of this trademark filing is NOT AVAILABLE since Monday, June 19, 2017.
0 
Star